CASE REPORT
Concomitant cancers in AIDS patients: a case report from Iran
More details
Hide details
1
Clinical TB and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Submission date: 2021-12-11
Final revision date: 2022-02-19
Acceptance date: 2022-02-21
Publication date: 2023-04-03
HIV & AIDS Review 2023;22(2):177-179
KEYWORDS
TOPICS
ABSTRACT
Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) are worldwide problems that lead to high rates of morbidity and mortality. Malignancies are important causes of death among patients; lymphoma and Kaposi sarcoma are the most common malignancies in HIV-positive and AIDS patients, but concurrence of these cancers in the same patient has rarely been reported.
We present a 33-year-old female patient who had been diagnosed with an AIDS-related high-grade central nervous system lymphoma, based on results of stereotactic biopsy, and had undergone radiotherapy and combined antiretroviral therapy. She was referred to our center with a productive cough, bilateral lung nodules, and skin lesion. Computed tomography-guided biopsies of skin lesion and pulmonary nodules were compatible with Kaposi sarcoma. Patient's pulmonary nodules and skin lesion resolved over the course of therapy, based on imaging findings; her brain lesions did not progress.
These findings suggest that dual malignancies related to HIV infection can occur in patients who are receiving antiretroviral therapy and have virologic suppression.
To our knowledge, concomitant malignancies in HIV-positive or AIDS patients are rare, and the authors would like to advocate the assessment of dual cancers among these patients to optimize therapeutic course and outcome.
REFERENCES (15)
1.
Fettig J, Swaminathan M, Murrill CS, Kaplan JE. Global epidemiology of HIV. Infect Dis Clin North Am 2014; 28: 323-337.
2.
Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016; 72 Suppl 3: S210-S219.
3.
Kilmarx PH. Global epidemiology of HIV. Curr Opin HIV AIDS 2009; 4: 240-246.
4.
Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS 2014; 28: 453-465.
5.
Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009; 23: 2337-2345.
6.
Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi’s sarcoma and non-Hodgkin’s lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999; 319: 23-24.
7.
Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 2017; 12: 6-11.
8.
Cesarman E. Pathology of lymphoma in HIV. Curr Opin Oncol 2013; 25: 487-494.
9.
Saple DG, Shah I, Surjushe AU, Murthy A, Chudgar P, Gote PD. Lymphoma in HIV patients: varied presentations. Indian J Med Paediatr Oncol 2010; 31: 39-42.
10.
Bacchi CE, Bacchi MM, Rabenhorst SH, et al. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. Am J Clin Pathol 1996; 105: 230-237.
11.
Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99: 2331-2336.
12.
Boulanger E, Daniel MT, Agbalika F, Oksenhendler E. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol 2003; 73: 143-148.
13.
Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005; 19: 851-855.
14.
Yanik EL, Achenbach CJ, Gopal S, et al. Changes in clinical context for Kaposi’s sarcoma and non-hodgkin lymphoma among people with HIV infection in the United States. J Clin Oncol 2016; 34: 3276-3283.
15.
Kim SE, Jung Y, Oh TH, et al. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt’s lymphoma and Kaposi’s sarcoma. BMC Cancer 2018; 18: 1080. doi: 10.1186/s12885-018-5019-9.